KLRD1 and neuroblastoma: ,46 In neuroblastoma, ligands for the NK cell receptors NKGD2 and DNAM-1 NK-AR are inhibited and NK cell-mediated innate immunity is suppressed,44 which has been reported to be associated with the inactivation of p53.